Back to search

Ireland· IE-PA-EU/1/03/253/01-3

Aldurazyme 100 U/ml concentrate for solution for infusion

A laronidase product containing laronidase, registered in Ireland by Sanofi B.V.. The same ATC class is registered in 12 of our 19 countries.

ATC A16AB05

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedAldurazyme 100 U/ml concentrate for s…ATCA16AB05REGISTER NO.IE-PA-EU/1/03/253/01-3PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Laronidase is registered in 12 of 19 countries.

Countries holding a registration under ATC A16AB05 (laronidase), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 7 of them publish a price we can compare per daily dose

Laronidase · ATC A16AB05

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Laronidase
Manufacturer
Sanofi B.V.
Country
Ireland (IE)
ATC code
A16AB05
ATC class
Laronidase
Defined daily dose
1 TSD, E
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    EU/1/03/253/01-3

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

2 interactions on record for laronidase.

Graded by severity as the source publishes them — 2 minor. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Laronidase · interactions on record

2 records

Interaction register. Grades as the source publishes them.

Same medicine, other countries

Laronidase in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All laronidase products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Aldurazyme
  • Liechtenstein · Aldurazyme
  • Norway · Aldurazyme

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c5dbba20-be8c-4ca0-925e-26083220fb92
GET /v1/drugs/c5dbba20-be8c-4ca0-925e-26083220fb92?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Concentrate for solution for infusion",
  "routes": [
    "Intravenous use"
  ],
  "source": "hpra",
  "atc_all": [
    "A16AB",
    "A16AB05"
  ],
  "strength": null,
  "pa_number": "EU/1/03/253/01-3",
  "substances": [
    "Laronidase"
  ],
  "legal_basis": "New active substance (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Unknown",
  "authorised_at": "10/06/2003",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about laronidase.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.